Status:

UNKNOWN

Psychobiological Responses to Choral Singing in Mentally Ill and Healthy Children and Adolescents

Lead Sponsor:

University of Salzburg

Collaborating Sponsors:

Universität Mozartuem Salzburg

Salzburger Landeskliniken

Conditions:

Stress

Eligibility:

All Genders

10-18 years

Phase:

NA

Brief Summary

Interventional, three-armed, open, monocentric, medium-term follow-up, pre-test-post-test design, controlled, parallel group study to investigate the effects of a group singing intervention on neuroen...

Detailed Description

Background: Biopsychological responses to music-related activities (MRA) were examined in various naturalistic settings in adults. Group singing in particular seems to be associated with positive biop...

Eligibility Criteria

Inclusion

  • Inclusion Criteria (Clinical N):
  • Written consent to study participation;
  • Gender: male, female, different;
  • Age: children and adolescents aged ≥ 10 and ≤ 18 years;
  • Diagnosis of a psychiatric disorder according to ICD-10;
  • Patients are admitted regardless of medication status and are allowed to the medication will continue to be used during the study;
  • Additional therapies and medication are recorded and are not an exclusion criterion;
  • Musical skills or a certain musical background are not required
  • Inclusion Criteria (Healthy N):
  • Written consent to study participation;
  • Gender: male, female, different;
  • Age: children and adolescents aged ≥ 10 and ≤ 18 years;
  • Musical skills or a certain musical background are not required
  • Exclusion Criteria (Clinical N):
  • Age: children and adolescents aged \<10 years and \> 18 years;
  • Criteria that prevent an application: hearing loss, states of confusion, inability to verbalize;
  • Patients with acute externalizing behavior or self-harm/suicidality;
  • Existing alcohol addiction or abuse of illegal drugs;
  • Exclusion Criteria (Healthy N):
  • Age: children and adolescents aged \<10 years and \> 18 years
  • Criteria that prevent an application: hearing loss, states of confusion, inability to verbalize

Exclusion

    Key Trial Info

    Start Date :

    August 1 2021

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    July 1 2023

    Estimated Enrollment :

    135 Patients enrolled

    Trial Details

    Trial ID

    NCT04454736

    Start Date

    August 1 2021

    End Date

    July 1 2023

    Last Update

    May 19 2022

    Active Locations (3)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (3 locations)

    1

    Salzburger Landeskliniken, Universitätsklinik für Kinder- und Jugendpsychiatrie

    Salzburg, Austria, 5020

    2

    University Mozarteum Salzburg/University of Salzburg

    Salzburg, Austria, 5020

    3

    University of Vienna

    Vienna, Austria, 1010